dalteparin has been researched along with Infections, Staphylococcal in 5 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 3 (60.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ruiz-Valverde, MP | 1 |
Barberà , JR | 1 |
Segarra, A | 1 |
Capdevila, JA | 1 |
Evangelista, A | 1 |
Piera, L | 1 |
Peetermans, M | 1 |
Liesenborghs, L | 1 |
Peerlinck, K | 1 |
Wijngaerden, EV | 1 |
Gheysens, O | 1 |
Goffin, KE | 1 |
Hoylaerts, MF | 1 |
Jacquemin, M | 1 |
Verhaegen, J | 1 |
Peetermans, WE | 1 |
Verhamme, P | 1 |
Vanassche, T | 1 |
Lai, TF | 1 |
Wu, J | 1 |
Henderson, T | 1 |
Winlaw, W | 1 |
Malcolm, SJ | 1 |
Ziakas, A | 1 |
Konstantinou, V | 1 |
Giannoglou, G | 1 |
Gemitzis, K | 1 |
Louridas, G | 1 |
1 trial available for dalteparin and Infections, Staphylococcal
Article | Year |
---|---|
Targeting Coagulase Activity in Staphylococcus aureus Bacteraemia: A Randomized Controlled Single-Centre Trial of Staphylothrombin Inhibition.
Topics: Administration, Intravenous; Administration, Oral; Aged; Aged, 80 and over; Anticoagulants; Antithro | 2018 |
4 other studies available for dalteparin and Infections, Staphylococcal
Article | Year |
---|---|
Successful treatment of catheter-related sepsis and extraluminal catheter thrombosis with vancomycin and fraxiparin without catheter removal.
Topics: Adult; Anti-Bacterial Agents; Anticoagulants; Bacteremia; Catheterization, Central Venous; Catheters | 1997 |
Septic superior ophthalmic vein thrombosis: to coagulate or not to coagulate?
Topics: Anticoagulants; Bacteremia; Enoxaparin; Humans; Orbit; Orbital Diseases; Staphylococcal Infections; | 2002 |
Septic superior ophthalmic vein thrombosis: enoxaparin needs to be monitored.
Topics: Anticoagulants; Bacteremia; Drug Monitoring; Enoxaparin; Humans; Orbit; Orbital Diseases; Staphyloco | 2002 |
Enoxaparin-induced psoas hematoma complicated by Staphylococcus aureus infection after cardiac catheterization.
Topics: Cardiac Catheterization; Enoxaparin; Follow-Up Studies; Hematoma; Humans; Male; Middle Aged; Staphyl | 2006 |